www.the-scientist.com/notebook/why-is-cancer-more-common-in-men-than-in-women--65640
''Understanding sex differences in cell biology more generally will be key to developing better treatments for cancer, says Christine Disteche, a geneticist at the University of Washington in Seattle who serves on the council of the Organization for the Study of Sex Differences. She notes that the National Institutes of Health (NIH) is looking in this direction. “Now there is a big push to add on studies comparing male and female” across biomedical research, she says.
Rubin says he thinks it’s about time, noting that clinical trials that lump the two sexes together will fail to find optimal treatments for either. “In an era where people love to talk about personalized medicine, [the fact] that personalizing to a person’s sex has not been part of that conversation is incredible to me.”